335 related articles for article (PubMed ID: 28827777)
1. Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system.
Han L; Chen J; Ding K; Zong H; Xie Y; Jiang H; Zhang B; Lu H; Yin W; Gilly J; Zhu J
Sci Rep; 2017 Aug; 7(1):8360. PubMed ID: 28827777
[TBL] [Abstract][Full Text] [Related]
2. Naturally split intein Npu DnaE mediated rapid generation of bispecific IgG antibodies.
Han L; Zong H; Zhou Y; Pan Z; Chen J; Ding K; Xie Y; Jiang H; Zhang B; Lu H; Gilly J; Zhu J
Methods; 2019 Feb; 154():32-37. PubMed ID: 30308314
[TBL] [Abstract][Full Text] [Related]
3. Kinetics study of the natural split Npu DnaE intein in the generation of bispecific IgG antibodies.
Zong H; Han L; Chen J; Pan Z; Wang L; Sun R; Ding K; Xie Y; Jiang H; Lu H; Gilly J; Zhang B; Zhu J
Appl Microbiol Biotechnol; 2022 Jan; 106(1):161-171. PubMed ID: 34882254
[TBL] [Abstract][Full Text] [Related]
4. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
[TBL] [Abstract][Full Text] [Related]
5. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics.
Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I
MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309
[TBL] [Abstract][Full Text] [Related]
6. Construction of IgG-Fab
Yamada R; Nakahara I; Kumagai I; Asano R; Nakanishi T; Makabe K
Sci Rep; 2023 Sep; 13(1):15961. PubMed ID: 37749185
[TBL] [Abstract][Full Text] [Related]
7. A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer.
Hou W; Yuan Q; Yuan X; Wang Y; Mo W; Wang H; Yu M
Invest New Drugs; 2019 Oct; 37(5):876-889. PubMed ID: 30511201
[TBL] [Abstract][Full Text] [Related]
8. Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing.
Akiba H; Ise T; Nagata S; Kamada H; Ohno H; Tsumoto K
Sci Rep; 2021 Sep; 11(1):19411. PubMed ID: 34593913
[TBL] [Abstract][Full Text] [Related]
9. A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.
Huang S; Segués A; Hulsik DL; Zaiss DM; Sijts AJAM; van Duijnhoven SMJ; van Elsas A
J Immunol Methods; 2020 Aug; 483():112811. PubMed ID: 32569598
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.
Michaelson JS; Demarest SJ; Miller B; Amatucci A; Snyder WB; Wu X; Huang F; Phan S; Gao S; Doern A; Farrington GK; Lugovskoy A; Joseph I; Bailly V; Wang X; Garber E; Browning J; Glaser SM
MAbs; 2009; 1(2):128-41. PubMed ID: 20061822
[TBL] [Abstract][Full Text] [Related]
11. An efficient process of generating bispecific antibodies via controlled Fab-arm exchange using culture supernatants.
Paul S; Connor J; Nesspor T; Haytko P; Boakye K; Chiu ML; Jiang H
Protein Expr Purif; 2016 May; 121():133-40. PubMed ID: 26826313
[TBL] [Abstract][Full Text] [Related]
12. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y
Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243
[TBL] [Abstract][Full Text] [Related]
13. A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.
Schanzer JM; Wartha K; Croasdale R; Moser S; Künkele KP; Ries C; Scheuer W; Duerr H; Pompiati S; Pollman J; Stracke J; Lau W; Ries S; Brinkmann U; Klein C; Umana P
J Biol Chem; 2014 Jul; 289(27):18693-706. PubMed ID: 24841203
[TBL] [Abstract][Full Text] [Related]
14. A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer.
Zhou Y; Zong H; Han L; Xie Y; Jiang H; Gilly J; Zhang B; Lu H; Chen J; Sun R; Pan Z; Zhu J
J Exp Clin Cancer Res; 2020 May; 39(1):87. PubMed ID: 32398042
[TBL] [Abstract][Full Text] [Related]
15. Generation of camelid VHH bispecific constructs via in-cell intein-mediated protein trans-splicing.
Shibuya Y; Haga N; Asano R; Nakazawa H; Hattori T; Takeda D; Sugiyama A; Kurotani R; Kumagai I; Umetsu M; Makabe K
Protein Eng Des Sel; 2017 Jan; 30(1):15-21. PubMed ID: 27881685
[TBL] [Abstract][Full Text] [Related]
16. Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies.
Rajendra Y; Peery RB; Hougland MD; Barnard GC; Wu X; Fitchett JR; Bacica M; Demarest SJ
Biotechnol Prog; 2017 Mar; 33(2):469-477. PubMed ID: 27977915
[TBL] [Abstract][Full Text] [Related]
17. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.
Strop P; Ho WH; Boustany LM; Abdiche YN; Lindquist KC; Farias SE; Rickert M; Appah CT; Pascua E; Radcliffe T; Sutton J; Chaparro-Riggers J; Chen W; Casas MG; Chin SM; Wong OK; Liu SH; Vergara G; Shelton D; Rajpal A; Pons J
J Mol Biol; 2012 Jul; 420(3):204-19. PubMed ID: 22543237
[TBL] [Abstract][Full Text] [Related]
18. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.
Froning KJ; Leaver-Fay A; Wu X; Phan S; Gao L; Huang F; Pustilnik A; Bacica M; Houlihan K; Chai Q; Fitchett JR; Hendle J; Kuhlman B; Demarest SJ
Protein Sci; 2017 Oct; 26(10):2021-2038. PubMed ID: 28726352
[TBL] [Abstract][Full Text] [Related]
19. Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain.
Dimasi N; Fleming R; Sachsenmeier KF; Bezabeh B; Hay C; Wu J; Sult E; Rajan S; Zhuang L; Cariuk P; Buchanan A; Bowen MA; Wu H; Gao C
MAbs; 2017 Apr; 9(3):438-454. PubMed ID: 28055299
[TBL] [Abstract][Full Text] [Related]
20. Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies.
Wu X; Sereno AJ; Huang F; Zhang K; Batt M; Fitchett JR; He D; Rick HL; Conner EM; Demarest SJ
MAbs; 2015; 7(2):364-76. PubMed ID: 25611120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
